Long term efficacy and tolerability of indiplon-ir in the treatment of chronic insomnia: Results of a double-blind, placebo-controlled 3-month study

被引：0
|
作者：
Scharf, MB
Black, J
Hull, S
Mahowald, M
Moscovitch, A
Farber, R
Jochelson, P
机构：
[1] Tri State Sleep Disorders Ctr, Cincinnati, OH USA
[2] Sleep Clin San Francisco, San Francisco, CA USA
[3] Vince & Associates Clin Res, Overland Pk, KS USA
[4] Minnesota Reg Sleep Disorders Ctr, Minneapolis, MN USA
[5] CSI Res Ctr, Calgary, AB, Canada
[6] Neurocrine Biosci, San Diego, CA USA
来源：
SLEEP | 2005年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
682
引用
收藏
页码：A229 / A229
页数：1
相关论文
共 50 条
  • [41] Efficacy of individualized homeopathic treatment of insomnia: Double-blind, randomized, placebo-controlled clinical trial
    Michael, James
    Singh, Subhas
    Sadhukhan, Satarupa
    Nath, Arunava
    Kundu, Nivedita
    Magotra, Nitin
    Dutta, Susmit
    Parewa, Maneet
    Koley, Munmun
    Saha, Subhranil
    [J]. COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 43 : 53 - 59
  • [42] EFFICACY AND SAFETY OF PALIPERIDONE PALMITATE 3 MONTH FORMULATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Berwaerts, Joris
    Liu, Yanning
    Gopal, Srihari
    Nuamah, Isaac
    Xu, Haiyan
    Savitz, Adam
    Coppola, Danielle
    Schotte, Alain
    Remmerie, Bart
    Maruta, Nataliya
    Hough, David W.
    [J]. SCHIZOPHRENIA BULLETIN, 2015, 41 : S302 - S302
  • [43] CISAPRIDE IN THE TREATMENT OF CHRONIC FUNCTIONAL DYSPEPSIA - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY
    GOETHALS, C
    VANDEMIEROP, L
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 42 (02): : 261 - 267
  • [44] Melatonin in schizophrenic outpatients with insomnia: A double-blind, placebo-controlled study
    Kumar, P. N. Suresh
    Andrade, Chittaranjan
    Bhakta, Savita G.
    Singh, Nagendra M.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (02) : 237 - 241
  • [45] Efficacy and tolerability of almotriptan in adolescents: A randomized, double-blind, placebo-controlled trial
    Linder, Steven L.
    Mathew, Ninan T.
    Cady, Roger K.
    Finlayson, Gary
    Ishkanian, Gary
    Lewis, Donald W.
    [J]. HEADACHE, 2008, 48 (09): : 1326 - 1336
  • [46] A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects
    C Cercato
    V A Roizenblatt
    C C Leança
    A Segal
    A P Lopes Filho
    M C Mancini
    A Halpern
    [J]. International Journal of Obesity, 2009, 33 : 857 - 865
  • [47] A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects
    J Wilding
    L Van Gaal
    A Rissanen
    F Vercruysse
    M Fitchet
    [J]. International Journal of Obesity, 2004, 28 : 1399 - 1410
  • [48] Piracetam in patients with chronic vertigo - Results of a double-blind, placebo-controlled study
    Rosenhall, U
    Deberdt, W
    Friberg, U
    Kerr, A
    Oosterveld, W
    [J]. CLINICAL DRUG INVESTIGATION, 1996, 11 (05) : 251 - 260
  • [49] A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects
    Wilding, J
    Van Gaal, L
    Rissanen, A
    Vercruysse, F
    Fitchet, M
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (11) : 1399 - 1410
  • [50] Double-blind, randomized, placebo-controlled study to evaluate the efficacy and tolerability of rizatriptan with acetaminophen for the acute treatment of migraine
    Freitag, F. G.
    Diamond, M. L.
    Skobieranda, F.
    Diamond, S.
    [J]. HEADACHE, 2007, 47 (05): : 749 - 749
12345